These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1219 related articles for article (PubMed ID: 26272689)
1. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells. Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689 [TBL] [Abstract][Full Text] [Related]
2. Impact of Engineered Expression of Mitochondrial Association Factor 1b on English ED; Boyle JP mSphere; 2018 Oct; 3(5):. PubMed ID: 30333181 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690 [TBL] [Abstract][Full Text] [Related]
4. A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Shen Y; Zheng B; Sun H; Wu S; Fan J; Ding J; Gao M; Kong Q; Lou D; Ding H; Zhuo X; Lu S Infect Dis Poverty; 2023 Jun; 12(1):60. PubMed ID: 37322556 [TBL] [Abstract][Full Text] [Related]
5. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain. Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321 [TBL] [Abstract][Full Text] [Related]
6. Influence of Two Major Hernández-de-Los-Ríos A; Murillo-Leon M; Mantilla-Muriel LE; Arenas AF; Vargas-Montes M; Cardona N; de-la-Torre A; Sepúlveda-Arias JC; Gómez-Marín JE Front Cell Infect Microbiol; 2019; 9():413. PubMed ID: 31867288 [No Abstract] [Full Text] [Related]
8. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii. Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis. Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693 [TBL] [Abstract][Full Text] [Related]
10. A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection. Yin H; Zhao L; Wang T; Zhou H; He S; Cong H Parasit Vectors; 2015 Sep; 8():498. PubMed ID: 26420606 [TBL] [Abstract][Full Text] [Related]
11. Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are type 2-dependent. Thouvenin M; Candolfi E; Villard O; Klein JP; Kien T Parassitologia; 1997 Dec; 39(4):279-83. PubMed ID: 9802080 [TBL] [Abstract][Full Text] [Related]
12. Kinetics in parasite abundance in susceptible and resistant mice infected with an avirulent strain of Toxoplasma gondii by using quantitative competitive PCR. Luo W; Aosai F; Ueda M; Yamashita K; Shimizu K; Sekiya S; Yano A J Parasitol; 1997 Dec; 83(6):1070-4. PubMed ID: 9406781 [TBL] [Abstract][Full Text] [Related]
13. Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii. Kang KM; Lee GS; Lee JH; Choi IW; Shin DW; Lee YH Korean J Parasitol; 2004 Dec; 42(4):175-83. PubMed ID: 15591835 [TBL] [Abstract][Full Text] [Related]
14. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii. Zorgi NE; Costa A; Galisteo AJ; do Nascimento N; de Andrade HF Immunol Lett; 2011 Aug; 138(2):187-96. PubMed ID: 21545808 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice. Schlüter D; Deckert-Schlüter M; Lorenz E; Meyer T; Röllinghoff M; Bogdan C J Immunol; 1999 Mar; 162(6):3512-8. PubMed ID: 10092808 [TBL] [Abstract][Full Text] [Related]
16. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice. Wagner A; Förster-Waldl E; Garner-Spitzer E; Schabussova I; Kundi M; Pollak A; Scheiner O; Joachim A; Wiedermann U Int J Parasitol; 2009 Mar; 39(4):465-72. PubMed ID: 18938169 [TBL] [Abstract][Full Text] [Related]
17. Immune responses of different mouse strains after challenge with equivalent lethal doses of Toxoplasma gondii. Lee YH; Kasper LH Parasite; 2004 Mar; 11(1):89-97. PubMed ID: 15071833 [TBL] [Abstract][Full Text] [Related]
18. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Fischer HG; Nitzgen B; Reichmann G; Hadding U Eur J Immunol; 1997 Jun; 27(6):1539-48. PubMed ID: 9209508 [TBL] [Abstract][Full Text] [Related]
19. Lectins from ; Ramos EL; Santana SS; Silva MV; Santiago FM; Mineo TW; Mineo JR Front Cell Infect Microbiol; 2016; 6():164. PubMed ID: 27933277 [TBL] [Abstract][Full Text] [Related]
20. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. Hunter CA; Chizzonite R; Remington JS J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]